Form 4: Owens & Minor EVP, CEO, Patient Direct, Perry A. Bernocchi, Reports Stock Transaction
SEC Form 4 Filing
Perry A. Bernocchi, EVP, CEO, Patient Direct at Owens & Minor, Inc., reports disposition of 5,551 shares of common stock to cover tax obligations related to vesting restricted stock.
Summary
- On March 20, 2025, Perry A. Bernocchi, EVP, CEO, Patient Direct at Owens & Minor, Inc., disposed of 5,551 shares of common stock.
- The transaction was executed to satisfy tax withholding obligations related to the vesting of restricted stock.
- The price per share was $10.09.
- Following the transaction, Bernocchi directly owns 247,360 shares of Owens & Minor common stock.
Sentiment
Score: 5
Explanation: Neutral. This is a standard transaction related to tax obligations on vested stock, with no inherent positive or negative implications for the company's overall performance.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This transaction is related to tax obligations from vesting restricted stock, a common form of executive compensation.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a routine sale of shares by an executive to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 03/20/2025 | Date of stock transaction (disposal of shares). |
| 03/24/2025 | Date of signature by Rosemarie France POA. |
Keywords
Form 4, Beneficial Ownership, Stock Transaction, Owens & Minor, OMI, Bernocchi, Restricted Stock, Tax Withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.